EN - European Commission

2. The quality criteria of the blood in the container remain unchanged. Documentation 1. Updated relevant sections and annexes of the PMF dossier, including the name of container, manufacturer, anticoagulant solution specification, confirmation of CE-mark and the name of the blood establishments where the container is used. ................
................